Paige Twenter / beckershospitalreview - In a deal worth $7.8 billion, Gilead Sciences has entered a definitive agreement to acquire Arcellx, a biotech company developing a cell therapy for multiple myeloma. Gilead announced the acquisition agreement a few months after Arcellx published positive…
#healthcare #pharmaceuticals #biotech #mergersandacquisitions #corporatetakeover #drugdevelopment #fda #oncology
Monday, February 23, 2026, 4:23 pm / permalink 19605 / 7 stories in 15 days
Sydney Halleman / healthcaredive - The DOJ filed a lawsuit last week accusing OhioHealth of leveraging its market power to force insurers to include its providers in their networks.
Monday, February 23, 2026, 2:23 pm / permalink 19594 / 7 stories in 15 days
esmo - Findings from the KEYNOTE-905/EV-303 study
#healthcare #pharmaceuticals #biotech #drugdevelopment #oncology
Monday, February 23, 2026, 2:22 am / permalink 19558 / 15 stories in 16 days
oncodaily - International Association for the Study of Lung Cancer (IASLC) shared a post on LinkedIn: “2026 TTLC Symposia Event Data and Decisions in Advanced NSCLC The treatment landscape for advanced NSCLC is evolving […]
#healthcare #pharmaceuticals #biotech #drugdevelopment #oncology
Monday, February 23, 2026, 2:22 am / permalink 19557 / 23 stories in 16 days
Judge orders Leapfrog to remove safety grades for five Florida hospitals 3 stories in 21.1 hours
Daily multivitamin slows epigenetic aging in randomized COSMOS analysis 4 stories in 40.1 hours
Engineered CAR‑T cells secreting VEGF‑neutralizing scFvs boost solid‑tumor activity 6 stories in 54.2 hours
White House briefing triggered rapid drops in acetaminophen use in ERs 2 stories in 58.1 hours
MUSC Health buys large South Carolina multispecialty practice for $111M 4 stories in 58.2 hours
Eli Lilly launches Employer Connect to broaden GLP‑1 coverage 16 stories in 83.2 hours
Analysis finds small patient group drives majority of admissions and costs 2 stories in 83.2 hours
Springing forward worsens sleep and sparks health complaints 8 stories in 87.2 hours
Cancer Grand Challenges awards five teams bold funding for cancer research 67 stories in 94.2 hours
Belzutifan combinations highlighted at ASCO GU improve RCC outcomes 3 stories in 96.2 hours
NorthFeed Inc.
Disclaimer: The information provided on this website is intended for general informational purposes only. While we strive for accuracy, we do not guarantee the completeness or reliability of the content. Users are encouraged to verify all details independently. We accept no liability for errors, omissions, or any decisions made based on this information.
Bluesky: